Letters to the Editor
Reply to: Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary
F. Macaluso1, G. Guggino2, F. Ciccia3
- Dipartimento di Medicina di Precisione, Section of Rheumatology, Università della Campania L. Vanvitelli, Napoli, Italy.
- Dipartimento PROMISE, Università degli Studi di Palermo, Italy.
- Dipartimento di Medicina di Precisione, Section of Rheumatology, Università della Campania L. Vanvitelli, Napoli, Italy. francesco.ciccia@unicampania.it
CER13400
2021 Vol.39, N°1
PI 0224
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 32452343 [PubMed]
Received: 03/04/2020
Accepted : 09/04/2020
In Press: 20/05/2020
Published: 05/02/2021
